PATENT CLAIM ANALYSIS

Application Number: 16007340
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "330000"]

Abstract:
The present invention relates to inhibitors of C5a activity and their use in the treatment of cutaneous, neutrophilic, inflammatory diseases in a subject.

Claim (Index 1):
A method of treating Hidradenitis suppurativa (HS) or a HS-related disease in a subject, the method comprising: administering to the subject in need thereof an effective amount of an agent that inhibits C5a activity in the subject.

Metadata:
- Claim Count in Document: 40.0
- Percentile: 94.0
- Lexical Diversity: 1.13043
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14729865', '15127676', '13512334', '12011058', '10222464']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7408550832003212
- 35 USC 102 Novelty (BERT): 0.5185964741167137
- Combined Prediction Score: 0.7186292222919605
- Mean Citation Score: 297.5676400000001
- Max Citation Score: 302.56268
- Similarity Product: 232.68063585617543

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test